Detalhe da pesquisa
1.
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
Infection
; 44(5): 589-97, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27048184
2.
Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database.
Infection
; 43(3): 339-43, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25821204
3.
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
J Infect Dis
; 210(3): 354-62, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24446523
4.
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
J Med Virol
; 86(10): 1648-55, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25042976
5.
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
J Antimicrob Chemother
; 68(1): 200-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915463
6.
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy.
J Med Virol
; 83(3): 391-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21264858
7.
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen.
BMC Med Inform Decis Mak
; 11: 40, 2011 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21672248
8.
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
J Antimicrob Chemother
; 64(2): 398-410, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19515730
9.
Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.
Biomed Pharmacother
; 62(1): 16-20, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17851026
10.
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.
Biomed Pharmacother
; 62(1): 6-11, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17574807
11.
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
Infect Drug Resist
; 11: 615-623, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29731650
12.
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir]. / Tossicità renale in pazienti con infezione da HIV in trattamento con HAART contenente tenofovir.
Infez Med
; 14(3): 125-34, 2006 Sep.
Artigo
em Italiano
| MEDLINE | ID: mdl-17127826
13.
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.
J Clin Virol
; 83: 48-53, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591555
14.
Low incidence of hepatotoxicity in a cohort of HIV patients treated with lopinavir/ritonavir.
AIDS
; 19(13): 1433-4, 2005 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16103779
15.
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Int J Antimicrob Agents
; 45(3): 289-94, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25476452
16.
Darunavir-based dual therapy in HIV experienced patients.
J Int AIDS Soc
; 17(4 Suppl 3): 19782, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25397526
17.
Decreasing cardiovascular risk in HIV infection between 2005 and 2011.
AIDS
; 28(4): 609-12, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24378754
18.
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study.
J Hypertens
; 31(3): 560-7; discussion 567, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23282895
19.
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Biomed Pharmacother
; 67(4): 293-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23433852
20.
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective study.
Biomed Pharmacother
; 66(5): 348-53, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22705335